EYLEA approved to treat macular edema in central retinal vein occlusion
Yesterday, the drug EYLEA (aflibercept), an anti-vascular endothelial growth factor (VEGF) antibody, was approved by the FDA to treat macular edema associated with central retinal vein occlusion (CRVO). A central retinal … Continue reading
September 22, 2012 · 1 Comment
Lucentis approved for the treatment of diabetic macular edema
The FDA recently approved Lucentis (ranibizumab) for the treatment of diabetic macular edema (DME) (swelling in the retina due to diabetes). I am intimately familiar with Lucentis as I commonly use it … Continue reading
September 2, 2012 · Leave a comment
